217 related articles for article (PubMed ID: 7527876)
21. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
[TBL] [Abstract][Full Text] [Related]
22. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
[TBL] [Abstract][Full Text] [Related]
23. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
24. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
25. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
[TBL] [Abstract][Full Text] [Related]
26. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
27. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
28. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence.
Kanwar YS; Rosenzweig LJ; Linker A; Jakubowski ML
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2272-5. PubMed ID: 6572976
[TBL] [Abstract][Full Text] [Related]
29. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.
Jyothirmayi GN; Reddi AS
Hypertension; 1993 Jun; 21(6 Pt 1):795-802. PubMed ID: 8500860
[TBL] [Abstract][Full Text] [Related]
30. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
31. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
Cohen MP; Surma ML
J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
[TBL] [Abstract][Full Text] [Related]
32. Glomerular permeability to neutral and anionic dextrans in experimental diabetes.
Michels LD; Davidman M; Keane WF
Kidney Int; 1982 May; 21(5):699-705. PubMed ID: 6180213
[TBL] [Abstract][Full Text] [Related]
33. Changes in heparan sulfate correlate with increased glomerular permeability.
Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
[TBL] [Abstract][Full Text] [Related]
34. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
35. Glycosaminoglycan synthesis by glomeruli in vivo and in vitro.
Brown DM; Michael AF; Oegema TR
Biochim Biophys Acta; 1981 Apr; 674(1):96-104. PubMed ID: 6786359
[TBL] [Abstract][Full Text] [Related]
36. Heparan sulfate analysis from diabetic rat glomeruli.
Lauer ME; Hascall VC; Wang A
J Biol Chem; 2007 Jan; 282(2):843-52. PubMed ID: 17038308
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
38. Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
Whiteside C; Templeton DM
Can J Physiol Pharmacol; 1992 Aug; 70(8):1096-103. PubMed ID: 1473041
[TBL] [Abstract][Full Text] [Related]
39. De novo cellular synthesis of sulfated proteoglycans of the developing renal glomerulus in vivo.
Kanwar YS; Jakubowski ML; Rosenzweig LJ; Gibbons JT
Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7108-11. PubMed ID: 6239287
[TBL] [Abstract][Full Text] [Related]
40. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study.
Ina K; Kitamura H; Nakamura M; Ono J; Takaki R
J Diabet Complications; 1991; 5(2-3):173-5. PubMed ID: 1770036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
